Companies/Oxford Investments Holdings Inc.

Company profile

Oxford Investments Holdings Inc.

OTC: OXIHF · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Toronto, ONReports USD

#1058 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 33

v0.1 · 5/100 weight · pillars only

↑ listing tenure, growth stability · ↓ workforce scale, Piotroski F

Methodology →

Revenue TTM

$7.2k

Rev growth YoY (TTM)

-90.6%

Net income (FY)

-$299.1k

Employees

Market cap

$72.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$61.2k$61.2k2020

Net income-$299.1k-$299.1k2020

Operating income-$342.3k-$342.3k2020

Total assets$451.1k$451.1k2020

Liabilities$1.0M$1.0M2020

Equity-$473.8k-$473.8k2020

Revenue trend

FY2015 – FY2020 · USD

$113.0k

FY15

$135.9k

FY16

$74.2k

FY17

$175.9k

FY18

$317.1k

FY19

$61.2k

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Oxford Investments Holdings Inc. booked $61.2k in FY2020 revenue, contracting 81% year over year — slower than 88% of Healthcare companies we track, at a -489.0% net margin.

Peers · Healthcare

Psykey, Inc.——Sigyn Therapeutics, Inc.——Cannonau Corp.——Wellstar International, Inc.——

Key facts

CEOMichael Donaghy

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersToronto, ON

ExchangeOTC: OXIHF

Employees1

IPO date2004-05-17

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.